#LEUsm
LightNews LightNews
drmiguelperales.bsky.social
If you're interested in Stem cell transplant and/or Cellular Therapy this is the list #bmtsm #CARTcells #leusm #mmsm #lymsm #MedSky #TcellRx go.bsky.app/7xxh8WW
November 22, 2024 at 2:33 PM
drmiguelperales.bsky.social
No surprise running into @penncancer.bsky.social @bllphd.bsky.social at the #ASH24 #CARTcells for AML session #leusm
December 8, 2024 at 1:20 AM
drmiguelperales.bsky.social
On my way to @ash-hematology.bsky.social #ASH24 & sharing this starterpack for HCT, #CARTcells & #genetherapy - > 100 members DM/comment if I missed someone #bmtsm #mmsm #leusm #lymsm #sicklecell #mpnsm #medsky

go.bsky.app/7xxh8WW
December 5, 2024 at 12:32 PM
kmirza.bsky.social
What story does this bone marrow tell you? #leusm #mdssm #mpnsm #hemepath
February 25, 2025 at 1:30 AM
tmprowell.bsky.social
🧵 EPA has banned 2 VOCs, called TCE & perc, found in dry cleaning solution, spot removers, car paint, glues, furniture care, degreasing agents, & more. They are known to be assoc with #cancer, #Parkinsons, & stillbirth.

#OncoAlert #kcsm #leusm #lymsm #MedSky #OncSky

Link below
December 9, 2024 at 8:03 PM
razanmohty.bsky.social
How I Treat #BPDCN
@ash-hematology.bsky.social @mkd-bmt.bsky.social #ASH24 #leusm

ashpublications.org/blood/articl...
December 5, 2024 at 4:16 AM
hemedoc.bsky.social
#ASH24 #leusm Eissa: real world data re FLT3i maintenance post-allo. 171 with, 269 wo maintenance. Most received sorafenib.
December 9, 2024 at 7:25 PM
hemedoc.bsky.social
#ASH24 #leusm Rao: based on available data it can be extrapolated that Blin should be part of 1L therapy for most B-ALL pts across age/risk groups.
December 8, 2024 at 10:36 PM
tmprowell.bsky.social
STARTING SOON!

Tues 11/19/24 9:30-10:30a EST: US & EU #regulatory colleagues discuss #PedOnc & #AYACSM challenges in #cancer #DrugDevelopment.

cc @GRASPtweets @OncoAlert @ASCO @AmerAcadPeds

#leusm #sarcoma #btsm #lymsm #advocacy #OncSky #PedSky

Reg here for free: surveymonkey.com/r/5TNRXV5
November 19, 2024 at 2:10 PM
oncbrothers.bsky.social
2024 approvals: Summary of 12 new 💊indications in heme malignancies by FDA:

1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib

#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm
December 24, 2024 at 3:07 AM
hemedoc.bsky.social
#tandem25 #leusm Al Malki: HR for relapse 47.5 (overall) in those with positive microchimerism vs those not.
February 13, 2025 at 1:37 AM
joshuafein.bsky.social
Can we rebuild the conversation here? #bmtsm #leusm — I have learned so much from reading in the old place.
November 18, 2024 at 2:19 AM
hemedoc.bsky.social
#ASH24 #leusm Eissa: no diff between sorafenib vs gilt. Unfortunately, no pre-HCT MRD data to compare these data directly with BMT-CTN 1506/MORPHO.
December 9, 2024 at 7:36 PM
hblackwell17.bsky.social
This is an amazing way to start the holiday season. Donate to your food charity of choice and join in. Food insecurity is one overlooked factor many cancer patients faced when going thru treatment. #HCWvsHunger #medSKY #BMTsm #leusm #cancer
November 26, 2024 at 7:15 PM
leukemiamd.bsky.social
Great to be a part of this committee! To the hill we go to #Fight4Hematology
#medsky #HemeSky
#ConquerSCD
#leusm
ash.hematology.org American Society of Hematology @ash.hematology.org · Feb 24
The ASH Committee on Government Affairs is gearing up to take its advocacy to Capitol Hill tomorrow! ASH is ready to #Fight4Hematology and push for policies that advance #hematology research and patient care.

Stay tuned for updates! 🏛️💪🔬

#ConquerSCD #HemeSky #BloodSky
February 25, 2025 at 3:57 AM
ash.hematology.org
📅 Join the next webinar from the ASH Subcommittee on #PrecisionMedicine

Explore how single-cell tools are transforming hematologic disease research and clinical care with insights into MGUS, SMM, and AML.

Register now: bit.ly/40Ua03m

#HemeSky #BloodSky #Hematology #Leusm #MMsm
January 29, 2025 at 5:22 PM
ash.hematology.org
Rohan, who has acute myeloid leukemia, says he’s alive today because of federally funded research. His story is a powerful reminder: Research saves lives. Learn more: https://ow.ly/xH3q50X4EOI

#Fight4Hematology #ResearchSavesLives #Leusm #HemeOnc
October 3, 2025 at 1:02 PM
hemedoc.bsky.social
#ASH24 #leusm Heuser: Proposes a reasonable evolution for the meaning of the term MRD. @drchrishourigan.bsky.social @rahulbanerjeemd.bsky.social
December 7, 2024 at 6:13 PM
hemedoc.bsky.social
Mido of no benefit in non-FLT3-ITD mutated AML in combo with LDAC/Ven. #ASH24 #leusm
markgeyermd.bsky.social Mark Geyer, M.D. @markgeyermd.bsky.social · Dec 7
Response rates (72 vs 68%) and LFS/OS not sig diff between groups though better ORR and OS in FLT3-ITD subgroup. 4/9 relapses in FLT3-ITD were FLT3-wt. No clear advantage in other subgroups despite TKI target promiscuity of midostaurin (2/2). #leusm #ASH24
December 8, 2024 at 12:20 AM
ash.hematology.org
📅 Free Webinar Tomorrow!

Explore single-cell technologies in hematology at our webinar: Single Cell Multi-omics in Precision Medicine.

🔗 Register now: ow.ly/rNwW50UPGyp

#Hematology #PrecisionMedicine #Leusm #MMsm #HemeSky #BloodSky
February 10, 2025 at 7:56 PM
vjhemonc.bsky.social
We're so excited for our Post-ASH 2024 Highlights Webinar Series!🩸

Presentations & discussions on selected abstracts from #ASH24

Featuring leading #HemOnc experts

👉https://ow.ly/zc9Z50U6Nkp

#LeuSM #MPNsm #MMsm #LymSM #MDSsm
November 28, 2024 at 11:28 AM
hemedoc.bsky.social
#ASH24 #leusm Radich: @drchrishourigan.bsky.social showed that MAC allo may overcome pre-HCT AML MRD but RIC can not.
December 7, 2024 at 5:56 PM
ash.hematology.org
Mapping gene expression in space helps us understand blood cancers. Spatial transcriptomics reveals cell-to-cell interactions, bringing us closer to truly personalized care. Learn more: https://bit.ly/3IVyFOH
#HemeSky #MedSky #Leusm
August 28, 2025 at 6:00 PM
drmiguelperales.bsky.social
Great @astct workshop to discuss immune effector cell toxicities in DC today. A lot accomplished today & more work ahead of us. Big thanks to Marcela Maus & Fred Locke for co-chairing with me & Anna Hawkshead for support. #CARTcells #medsky #oncsky #lymsm #mmsm #leusm
November 20, 2024 at 11:30 PM
drhkantarjian.bsky.social
Check out our comprehensive review on #AML from an @mdanderson.bsky.social perspective, " Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges" published in @acsjournalcancer.bsky.social

acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
#leusm
April 1, 2025 at 1:16 PM